Loading...
Allogeneic CAR T Pipeline And AstraZeneca Partnership Will Drive Long-Term Upside
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
1Y
150.0%7D
-9.2%1Y
150.0%7D
-9.2%You can edit this narrative until Dec 11 6:10 AM. Then, changes will post as Updates.